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UNDERSTANDING THE MEANING OF THE FAMILY’S ACTIONS OF A CHILD
WITH CANCER UNDERGOING BONE MARROW TRANSPLANTATION IN A
BRAZILIAN PEDIATRIC ONCOLOGY INSTITUTION
Duarte, A.1, Porto, D.1, Pettengill, M.2 1 Instituto deOncologiaPediatrica-
GRAACC-Unifesp, Sa˜o Paulo, SP, Brazil; 2Universidade Federal de Sa˜o
Paulo, SP, Brazil
BoneMarrow Transplantation is a complex, long-term and agressive
process, wich may lead to lesions or fatal consequences. Even in suc-
cessful interventions there are repercussions in the child’s and family’s
lives, in physical, psychological aspects and their social interactions.
The aim of the study was to understand the meaning of the family’s ac-
tions of a child with cancer undergoing the Bone Marrow Transplan-
tation (BMT) in a Brazilian Institute of Pediatric Oncology. The
Symbolic Interactionism and Qualitative Content Analysis were the
theoretical and methodological frameworks applied. Interviews were
held with six families of childrenwith cancer undergoing BMT inphase
of post-transplant engraftment. Three thematic categories emerged
from data analysis: 1- The worsen of the child’s health condition.
When the family perceives the reoccurrence of the cancer and the
need of the transplantation; 2- BMT as the only chance for the child’s
survival. A time of sufferingbecause of the need tomake the decision;3-
The family’s zeal and responsibility for the child’s care to assure his/her
cure. This reveals that the family’s actions are guided by the moral re-
sponsibility of looking after the child. So the family does everything
yhat is necessary to reach the success of the treatment, as it means their
only option. The comprehension of the family’s actions enlarges the
theoretical knowledge contributing to abroad nurse’s understanding
of the family’s expericence and give sense to the propositions of nursing
interventions which may help families through difficult times.475
A PROGRAM’S APPROACH TO SUPPORTIVE CARE FOR COMMONCOMPLI-
CATIONS FOLLOWING BLOOD AND MARROW TRANSPLANT
Watson, E.H. OSU James Cancer Hospital, Columbus, OH
Recipients of blood and bone marrow transplants face a number of
unique and predictable complications throughout their treatment and
transplant course. These complications can be life-threatening and de-
bilitating, can increase the length of hospital stay and treatment costs,
and affect a patient’s comfort and quality of life. Some of these compli-
cations include: nausea and vomiting, diarrhea, mucositis, hemor-
rhagic cystitis, and hyperglycemia. Plans of care have been
developed to create consistent and evidence-based approaches to the
diagnosis, management, and treatment of these complications. These
plans of care were created following review of literature, analysis of re-
search, and with guidance from institutional specialists in these areas,
including physicians, pharmacists, and advance practice nurses. Out-
lines and algorithms have been designed for each of these complica-
tions. Pharmalogic management of nausea and vomiting is presented
with medication dosage and frequency along with anticipated side
effects. A comprehensive guide to the diagnosis and management of
diarrhea directs the practitioner through grading and managing the
multi-factoral etiologies of diarrhea. Preventative measures for muco-
sitis as well as risk factors, grading criteria, supportive care, topical
therapies, and pain management are included in this plan of care. Man-
agement of hemorrhagic cystitis is based on patient symptomatology
and guidelines provide appropriate diagnostic testing, supportive
care, and pharmacologic treatment. Common causes of hyperglyce-
mia in transplant patients, as well as treatment with oral hypoglycemic
agents and insulin, and patient education are outlined in this plan of
care. These plans of care have been adapted into blood and marrow
transplant policies and procedures and are available on the institu-
tional intranet. These policies and procedures provide the standards
of practice for the care of this specialized patient population and offer
consistency in treatment for these patients.476
CREATING CONTINUITY OF CARE: PRE-ADMISSION TRANSPLANT
EDUCATION
Febryani, I., Estrella, J.M., Brandert, M.K., Adornetto-Garcia, D.L.
M.D. Anderson Cancer Center, Houston, TXBackground: Patients scheduled for a stem cell transplant are faced
with many concerns, including: length of hospitalization, side effect
of chemotherapy, hospital routine, and discharge planning. Not
knowing what to expect can be a source of anxiety and emotional dis-
tress for patients and their caregivers. Results of a Patient Satisfac-
tion Survey reflected that patients felt information should be
provided prior to admission for transplant to set goals and expecta-
tions for the inpatient period.
Aim/Objectives: To create a Pre-admission class to address patient
questions related to hospitalization for stem cell transplant and eval-
uate its efficacy.
Intervention: A multidisciplinary workgroup assessed the expressed
and hypothetical educational needs of patients and their caregivers
prior to transplant. A pre-admission class, presented by discharge
nurses in collaboration with multidisciplinary staff, was developed
as a required part of the pre-transplant preparation process. The
class is held twice a week and targets all patients scheduled to be ad-
mitted to the transplant unit for either autologous or allogeneic
transplants. The class outlines the transplant process from the pre-
transplant work-up to the day of admission, the preparative chemo-
therapy regimen to the day of transplant, and the pathway to engraft-
ment to the day of discharge. A unit tour is provided at the end of the
class. The class reinforces education provided in the clinic setting
prior to admission and at the bedside by nurses during the transplant
process.
Results/Evaluation: At the completion of the Pre-Admission class,
patients are asked to complete a survey related to the breadth of in-
formation provided and the ease of its use. Data from this survey, in
conjunction with data from the National Database of Nursing Qual-
ity Indicators (NDNQI) discharge survey, are evaluated to deter-
mine the usefulness of this intervention. Program design, survey
results and patient feedback will be presented to illustrate the efficacy
of implementing a Pre-Admission education program for patients
and caregivers preparing for SCTCT.477
SUPPORTIVE CARE PRACTICES: A SURVEY OF PEDIATRIC BLOOD & MAR-
ROW TRANSPLANT CONSORTIUM INSTITUTIONS
Fisher, V.L.4, Olsen, E.1, Skeens, M.A.2, Barnes, Y.3 1Children’s Health-
care of Atlanta, Atlanta, GA; 2Nationwide Children’s Hospital, Colum-
bus, OH; 3St.Louis Children’s Hospital, St. Louis, MO; 4Pediatric Bone
Marrow Transplant Consortium, Aracadia, CA
Purpose: This survey was designed to identify the supportive care
practices of pediatric blood and marrow transplant (BMT) patients
by institutions within the Pediatric Blood & Marrow Transplant
Consortium (PBMTC). A secondary aim is to develop clinical prac-
tice guidelines for the pediatric BMT patient.
Methods: A survey was distributed to all members electronically.
The survey was designed to collect information about institutional
demographics and BMT specific supportive care practices.
Results: 104 surveys were received. Allogeneic and autologous
transplants were performed at 99% of the institutions. Non-myeloa-
blative transplants were performed in 95% of centers. FACT accred-
itation was maintained in 94% of the institutions with 71% of the
programs being accredited as a pediatric allogeneic and autologous
center. 87% of programs utilized mid level practitioners and 98%
of the programs had designated BMT physicians. 60% of the institu-
tions provided 24/7 BMT team coverage. The majority of institu-
tions had a designated BMT unit with age specific visitation
restrictions. The survey requested responses for general and specific
supportive care practices for the following: central venous catheter
type (double lumen CVL 88%), physical therapy (84% routinely
consulted PT), mucositis prophylaxis (Glutamine 36% and Palifer-
min 34%) and mucositis management (narcotic infusions and magic
mouthwash). Menses control is maintained with oral contraceptives
in the majority of centers. VOD prophylaxis is done with aggressive
IV fluid management, Actigall and daily weights. Over 95% of the
centers maintain PCP, viral and fungal prophylaxis in all BMT pa-
tients. The use of filgrastim is utilized in the majority of centers
(1/3 begins on Day +7). The majority of centers define fever as a tem-
perature of 38.5, and start dual therapy with Vancomycin. Persistent
fever is managed clinically with empiric anti-fungal medications
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fungal infections are utilized at the centers. The majority of centers
utilized hyperalimentation (96%) in their patients with 57% of the
centers using enteral feeds in conjunction with hyperalimentation.
Conclusion: Based on the responses submitted by the PBMTC
membership, the programs employ various supportive care practices.
These findings suggest a need to develop evidence based clinical
practice guidelines in the care of the pediatric BMT patient.478
A CLINICAL MICROSYSTEMS APPROACH TO REDUCE VANCOMYCIN-RE-
SISTANT ENTEROCOCCUS (VRE) INCIDENCE IN PATIENTS TRANS-
PLANTED IN A PEDIATRIC ONCOLOGY & STEM CELL TRANSPLANT UNIT
Neitz, S.H., Luzader, J., Borodkin, T., Andrea, K., Watts, A., Pletz, J.,
Slabaugh, R., Varga, L., Lerner, L., Smith, D., Li, X. Akron Children’s
Hospital, Akron, OH
The overall colonization rates of Vancomycin-resistant entero-
coccus (VRE) in patients with cancer and other chronic diseases
are high. On an inpatient unit combining Hematopoietic Stem
Cell Transplant (HSCT) patients with general hematology, oncol-
ogy, nephrology and orthopedic patients the high colonization
rates of VRE in these populations may be another risk factor for
transmission to HSCT patients in addition to their prolonged neu-
tropenia and multiple antimicrobial medications. VRE bacteremiasduring HSCT have been associated with high morbidity and mor-
tality. During the first quarter of 2009, 4 of our transplant patients
had symptomatically positive VRE stool cultures and 1 also had
VRE bacteremia. One of theses patients had sickle cell disease
and had no history of prolonged use of antibiotics prior to his pos-
itive VRE stool culture. All patients tested positive for the same
VRE strain, which was also identified in a non-transplant patient
hospitalized on the same inpatient unit. Therefore, a multidisciplin-
ary (Microsystems) team was established within our department to
implement and monitor the recommended infection prevention
measures put forth by the Center for Disease Control (CDC)
and Joint Commission. The multidisciplinary team was comprised
of staff from the inpatient and outpatient units, infection control,
environmental services and administration. The areas of focus in-
cluded judicious use of antibiotics, education of staff, patients
and families regarding hand hygiene compliance, standard and con-
tact precautions recommendations and adherence, and surveillance
for VRE. Patient and family surveys were conducted to identify the
possible causes of VRE transmission and educational needs of staff,
patients and families. A ‘‘VRE+’’ sticker was placed on the cover of
the patient’s medical chart and VRE positive status was communi-
cated to all ancillary care services. Our team met bi-weekly to up-
date the process. Through these interventions and the
reinforcement of the VRE policy, we are pleased to report there
have been no new patients with VRE infection in the second and
third quarter of the year for our inpatient and outpatient Hematol-
ogy and Oncology Units.
